Concepedia

Publication | Open Access

Efficacy and Safety of Dupilumab in Children With Peanut Allergy: A Multicenter, Open‐Label, Phase <scp>II</scp> Study

26

Citations

36

References

2024

Year

Abstract

Dupilumab monotherapy treatment for 24 weeks did not improve desensitization to peanut exposure after food challenge.

References

YearCitations

Page 1